KRAS and cancer: For the first time in the literature, we synthesized GEM-loaded NPs and evaluated their anti-cancer properties associated with oxidative stress, cellular toxicity, ferroptosis, glycolysis, and PPP metabolism using the CFPAC-1 cell line harboring KRAS and p53 mutations.